Experienced team, innovative treatment
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/90ebbb11-aed8-4e27-91f8-ddfcdca03dd1/17-DDI-3877-Quintini-CQD-Hero_jpg)
17-DDI-3877-Quintini-CQD-Hero
By Cristiano Quintini, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A 42-year-old female was referred to our institution with large right colon cancer and synchronous bilobar liver metastasis (see presenting CT scan of the liver above). A particular challenge was presented by the lesion encasing the three hepatic veins of the liver (see arrows).
The patient received three months of perioperative chemotherapy and was scheduled (three months after the initial presentation) for a two-stage hepatectomy and a combined resection of the primary right colon tumor.
The first surgery included a right hemicolectomy with resection of all the left-sided liver lesions. The surgery was uneventful. On postoperative day 6, the patient underwent a right portal vein embolization with the intent to induce hypotrophy of the right hemi liver and the hypertrophy of the left hemi liver. This approach is used to decrease the risks of postresection liver failure.
Six weeks after the first operation, the patient underwent a right hepatectomy. Given her young age and the extent of the disease, the decision was made to place to also place a hepatic artery infusion (HAI) pump to further decrease her likelihood of recurrence. HAI locoregional treatment is an innovative approach that improves survival after liver resection for metastatic colon cancer. This treatment option is only delivered in selected centers around the world.
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/336ab2a6-d780-428c-bfa0-43a6027e8fe5/17-DDI-3877-Quintini-CQD-Inset1_jpg)
The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.
One year after the initial presentation, the patient is free of tumor (see scan below) and receiving routine follow-up scans.
Advertisement
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/375db05f-5da2-45c9-9963-5600dbbcf5ee/17-DDI-3877-Quintini-CQD-Inset2_jpg)
CT scan showing the patient free of tumor.
Advertisement
Advertisement
Patients may benefit from booster appointments, psychological support
Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment
Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery
Large, retrospective study indicates improved outcomes after one and five years of treatment
Multidisciplinary collaboration is fueling breakthroughs in endoscopic and surgical technology
A surge in transplants, advanced surgical techniques and multidisciplinary collaboration has helped shape and expand the Liver Transplant Program
Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies
Benefits of neoadjuvant immunotherapy reflect emerging standard of care